U.S. Ambulatory Surgical Center Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Ambulatory Surgical Center Market 

5.1. COVID-19 Landscape: U.S. Ambulatory Surgical Center Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Ambulatory Surgical Center Market, By Ownership

8.1. U.S. Ambulatory Surgical Center Market, by Ownership, 2024-2034

8.1.1. Physician Only

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Hospital Only

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Corporation Only

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Physician & Hospital

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Physician & Corporation

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Hospital & Corporation

8.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 9. U.S. Ambulatory Surgical Center Market, By Surgery Type

9.1. U.S. Ambulatory Surgical Center Market, by Surgery Type, 2024-2034

9.1.1. Ophthalmology

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Dental

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Endoscopy

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Orthopedic

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Otolaryngology

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Obstetrics / Gynecology

9.1.6.1. Market Revenue and Forecast (2021-2034)

9.1.7. Neurology

9.1.7.1. Market Revenue and Forecast (2021-2034)

9.1.8. Cardiovascular

9.1.8.1. Market Revenue and Forecast (2021-2034)

9.1.9. Plastic Surgery

9.1.9.1. Market Revenue and Forecast (2021-2034)

9.1.10. OrthoPodiatrypedic

9.1.10.1. Market Revenue and Forecast (2021-2034)

9.1.11. Others

9.1.11.1. Market Revenue and Forecast (2021-2034)

Chapter 10. U.S. Ambulatory Surgical Center Market, By Specialty Type

10.1. U.S. Ambulatory Surgical Center Market, by Specialty Type, 2024-2034

10.1.1. Single specialty

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Multi-specialty

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. U.S. Ambulatory Surgical Center Market, By Service 

11.1. U.S. Ambulatory Surgical Center Market, by Service, 2024-2034

11.1.1. Diagnosis

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Treatment

11.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 12. U.S. Ambulatory Surgical Center Market, Regional Estimates and Trend Forecast

12.1. U.S.

12.1.1. Market Revenue and Forecast, by Ownership (2021-2034)

12.1.2. Market Revenue and Forecast, by Surgery Type (2021-2034)

12.1.3. Market Revenue and Forecast, by Specialty Type (2021-2034)

12.1.4. Market Revenue and Forecast, by Service (2021-2034)

Chapter 13. Company Profiles

13.1. Cerner Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Allscripts Healthcare Solutions Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. McKesson Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Medical Information Technology Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Advanced Data Systems Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Surgical Information Systems

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. NextGen Healthcare

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Philips Healthcare

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Epic Systems Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. GE Healthcare

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms